Is Cyanokit (hydroxocobalamin) effective for treating non-cyanide toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cyanokit (Hydroxocobalamin) for Non-Cyanide Toxicity

Cyanokit (hydroxocobalamin) is NOT recommended for non-cyanide toxicity and should be restricted exclusively to confirmed or highly suspected cyanide poisoning. 1, 2

Evidence-Based Restrictions

The most recent and authoritative guidelines explicitly limit hydroxocobalamin use:

  • The 2023 American Heart Association guidelines recommend hydroxocobalamin only for cyanide poisoning, specifically in patients with cardiac arrest, cardiovascular instability, metabolic acidosis, or altered mental status from known or suspected cyanide exposure 1

  • Routine administration after smoke inhalation is NOT recommended unless there is high suspicion of severe cyanide poisoning based on clinical criteria 2

  • The American Society of Anesthesiologists explicitly states that hydroxocobalamin should not be routinely administered after smoke inhalation, reserving it only for cases with high suspicion of severe cyanide poisoning 2

Specific Clinical Indications for Use

Hydroxocobalamin should ONLY be administered when the following criteria are met:

Adults 1, 3

  • Suspected cyanide exposure (fire smoke, industrial exposure, intentional poisoning) AND
  • Severe manifestations: cardiac arrest, cardiovascular collapse, shock, coma, or severe metabolic acidosis
  • Plasma lactate ≥8-10 mmol/L in the appropriate clinical context 2, 3

Pediatric Patients 2, 3

  • Smoke inhalation AND
  • Signs of moderate or severe cyanide poisoning (altered consciousness, cardiovascular instability)

Why Not for Non-Cyanide Toxicity?

Mechanism Specificity

Hydroxocobalamin works by directly binding cyanide ions to form cyanocobalamin (vitamin B12), which is then renally excreted 4, 5. This mechanism is entirely specific to cyanide and provides no therapeutic benefit for other toxins.

Potential Harms

  • Oxalate nephropathy can occur with hydroxocobalamin administration 3
  • Chromaturia and pink skin discoloration complicate clinical assessment 6
  • False elevation of laboratory values can interfere with diagnostic testing
  • Resource misallocation in mass casualty events if used inappropriately

Common Pitfalls to Avoid

Do NOT administer hydroxocobalamin for:

  • Carbon monoxide poisoning alone (without cyanide co-exposure) 2
  • General smoke inhalation without specific cyanide toxicity indicators 2
  • Other toxidromes (tricyclic antidepressants, cocaine, opioids, etc.) 1
  • Metabolic acidosis from non-cyanide causes
  • Empiric use in all fire victims 7

Critical Decision Point

The key distinguishing feature is severe metabolic acidosis (pH <7.20) or elevated lactate (≥8-10 mmol/L) in the context of potential cyanide exposure 8, 2. Without this context, hydroxocobalamin has no role.

Antidote Stocking Considerations

Hospital formularies stock hydroxocobalamin specifically for cyanide emergencies, not for broad toxicological use:

  • Immediate availability is recommended for emergency departments that accept poisoned patients 1
  • Hydroxocobalamin is preferred over sodium nitrite/sodium thiosulfate for cyanide poisoning due to superior safety profile 1
  • This preference is based on ease of use, wider indications, and lack of methemoglobin formation 1

Alternative Toxin-Specific Antidotes

For non-cyanide toxicities, use appropriate evidence-based antidotes 1:

  • Opioids: naloxone
  • Benzodiazepines: flumazenil (with caution)
  • Cardiac glycosides: digoxin-specific antibody fragments
  • Toxic alcohols: fomepizole
  • Cocaine cardiotoxicity: benzodiazepines, sodium bicarbonate for wide-complex dysrhythmias 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Smoke Inhalation Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hydroxocobalamin Dosing for Cyanide Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Which cyanide antidote?

Critical reviews in toxicology, 2009

Research

Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation.

The American journal of emergency medicine, 2007

Guideline

Cyanide Poisoning Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.